HorowitzC. R.RobinsonR. M.SeiferS. (2009). Community-based participatory research from the margins to the mainstream: Are researchers prepared?Circulation, 119, 2633-2642. doi:10.1161/CIRCULATIONAHA.107.729863
2.
LiuJ. J.BellC. M.MatelskiJ. J.DetskyA. S.CramP. (2017). Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: Retrospective observational study. British Medical Journal, 359, j4619. doi:10.1136/bmj.j4619
3.
RaoJ. N.CassiaL. J. (2002). Ethics of undisclosed payments to doctors recruiting patients in clinical trials. British Medical Journal, 325(7354), 36-37. doi:10.1136/bmj.325.7354.36
4.
ResnikD. (2015). Bioethical issues in providing financial incentives to research participants. Medicolegal and Bioethics, 5, 35-41. doi:10.2147/MB.S70416
5.
SimonC.MosavelM. (2010). Community members as recruiters of human subjects: Ethical considerations. American Journal of Bioethics, 10(3), 3-11. doi:10.1080/15265160903585578
6.
SismondoS. (2008). How pharmaceutical industry funding affects trial outcomes: Causal structures and responses. Social Science & Medicine, 66, 1909-1914. doi:10.1016/j.socscimed.2008.01.010
7.
TindanaP. O.SinghJ. A.TracyC. S.UpshurR. E.DaarA. S.SingerP. A.. . . LaveryJ. V. (2007). Grand challenges in global health: Community engagement in research in developing countries. PLoS Medicine, 4(9), e273. doi:10.1371/journal.pmed.0040273
8.
WertheimerA. (2010). Rethinking the ethics of clinical research: Widening the lens. Oxford, UK: Oxford University Press.
